NCT01592370 2025-10-22An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple MyelomaBristol-Myers SquibbPhase 1/2 Completed320 enrolled 35 charts
NCT00150462 2017-05-02Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological MalignanciesAmgenPhase 1 Completed48 enrolled 26 charts